Stock analysts at Barclays upped their price objective on shares ofForest Laboratories (NYSE:FRX) from $74.00 to $90.00 in a report issued on Wednesday, American Banking & Market News reports. The firm currently has an “equal weight” rating on the stock. Forest Laboratories, Inc. (NYSE:FRX) stock opened at $91.65 in last session, and closed at $93.98, while the day range of stock is $91.35 – $94.68. The stock showed a positive weekly performance of 35.22%.
Illumina, Inc. (NASDAQ:ILMN) announced that it will webcast its presentation at the Cowen and Company 34th Annual Health Care Conference in Boston, Massachusetts, on March 5, 2014. Illumina, Inc. (NASDAQ:ILMN) stock opened at $170.00, in last session and closed at $170.16, by losing -0.14%. The 52 week range of the stock is $48.00 – $173.98. Company’s market capitalization is $21.51 billion.
Novo Nordisk A/S (ADR) (NYSE:NVO) has begun an environmental profit and loss (EP&L) account to further integrate sustainability into its core business. Novo Nordisk A/S (ADR) (NYSE:NVO) stock decreased -0.54% and finished the last session at $44.09. The EPS of the stock remained 1.72. Company’s market capitalization is $117.09 billion.
NVIDIA Corporation (NASDAQ:NVDA) had its price target raised by analysts at UBS AG from $17.00 to $20.00. They now have a “buy” rating on the stock. NVIDIA Corporation (NASDAQ:NVDA) stock opened the session at $17.90, and closed the session at $18.14. The 52 week range of the stock remained $12.04 – $18.30 and the day range was $17.82 – $18.30.